DWTX — Dogwood Therapeutics

Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is f...

Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.

Industry
PHARMACEUTICAL PREPARATIONS
Sector
Healthcare
Exchange
NASD
First trade date
2020-12-17

The interactive platform loads with JavaScript. Research tools are for informational purposes.